Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SUBSTIPHARM

Home Clinical Trial Sponsors and OrganizationsSUBSTIPHARM

SUBSTIPHARM

24 RUE ERLANGER, Paris, Île-de-France, France

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

4

1 active

Approvals

21

Total approvals

Agencies

2

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

3

75.0%

Phase 4

1

25.0%

Trial Status Distribution

Active, not recruiting

1

25.0%

Completed

2

50.0%

Recruiting

1

25.0%

Clinical Trials

Trials sponsored by this organization (4)

A randomized, investigator masked pilot study to establish the experimental conditions and select the criteria to compare topical application of 2 methyl aminolevulinate creams: evaluation of protoporphyrin IX formation in the skin of healthy subjects.

Active, not recruiting

Apr 202412 participants

In vivo bioequivalence study of a new clobetasol propionate 0.05% topical cream compared to DERMOVAL® 0.05% cream using the skin blanching bioassay in healthy subjects.

Jul 2023102 participants

A randomized, investigator masked pilot study to establish the experimental conditions and select the criteria to compare topical application of 2 methyl aminolevulinate creams: evaluation of protoporphyrin IX formation in the skin of healthy subjects.

12 participants

In vivo bioequivalence study of a new clobetasol propionate 0.05% topical cream compared to DERMOVAL® 0.05% cream using the skin blanching bioassay in healthy subjects.

102 participants

Approvals

Approvals by Agency

EMA

European Medicines Agency

3

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

18

Approvals

Recent Approvals

MOTUFE 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL

MORCO 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL

MYCOSTATIN 100.000 UI/ml SUSPENSION ORAL

EFIENT 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

EFIENT 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

EFIENT 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

EFIENT 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

EFIENT 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

EVIANZIN 5 MG COMPRIMIDOS BUCODISPERSABLES EFG

LORITOZIN 5 MG COMPRIMIDOS BUCODISPERSABLES EFG

News

No news articles found

On this page

Overview
Clinical Trials4
Approvals21
News

Back to Organizations